Covance Blog
Do you understand the key changes for CERs? The interplay of MDR and MEDDEV is complex. The release of the revised guidance regarding Clinical Evaluations (MEDDEV 2.7/1 Rev. 4) in 2016 introduced some significant changes to the process of clinical evaluation. Now, even with the all but official postponement of …
The COVID-19 pandemic is driving a global demand for medical supplies, equipment and cleaning agents. In terms of PPE alone, the WHO estimates that there is a world-wide monthly demand for 89 million medical masks, 76 million examination gloves and 1.6 million goggles. To meet this demand, the WHO suggests …
Biomarkers and diagnostics are playing an ever-increasing role in drug development. Personalized medicines, defined as drug therapies used alongside specific diagnostic tests, topped 40% of all FDA approvals in 2018. Across biopharma, drug developers increased their utilization of selection biomarkers, significantly improving the probability of success for their clinical programs.1, …
From getting a promotion to organizing team-building events, Josey continues to grow her career at Covance and maintain connections with her team during the COVID-19 pandemic. After graduating with a bachelor’s degree in biology at the University of Wisconsin-La Crosse, Josey started her career at Covance in Madison, Wisc., US, …
In the age of COVID-19, patients can’t wait for new vaccines and therapies to come to the market. That is why even in these challenging times, Covance has been focused more than ever on understanding the patient perspective on clinical trial participation. As social distancing has become the new normal, …
We’re in this together: How Covance and LabCorp are delivering unmatched acceleration of COVID-19 diagnostic and therapeutic applications Accelerating much needed COVID-19 testing, vaccines and treatment options across the world can’t be done alone. We’re in this together and ready to apply our unique combination of solutions that blend Covance …
In an effort to help clients get faster clinical trial results and support development of today’s novel therapies, Covance recently expanded its Asia-Pacific footprint by becoming the first major central laboratory in Japan to add anatomic pathology and histology (APH) services at its Kawagoe facility. Learn more about how this …
An unprecedented challenge The coronavirus (Covid-19) pandemic has increased the demand for hand disinfectants, driven by recommendations from bodies such as the WHO. Hand washing is a vital measure for reducing the risk of contracting the virus. The WHO specifically recommends that all individuals “Regularly and thoroughly clean your hands …
After earning a dual degree in chemistry and business at University of Wisconsin-Eau Claire, Joshua had been growing his career at Covance, LabCorp’s drug development business, for seven years, starting as a quality assurance auditor before becoming a study coordinator and an associate pharmacokineticist. He considered himself healthy, which is …
The exact cause of ulcerative colitis (UC) is still unknown, but approximately 700,000 people in the United States suffer from this chronic, life-long disease that causes inflammation in the large intestine. A wide range of treatment options are available, but drug development sponsors are seeking additional ways to control inflammation, …
